Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia | Zendy

B. H. | Zendy; Ronald A. Cantrell | Zendy; I. Zulu | Zendy; Lloyd Mulenga | Zendy; Jens Levy | Zendy; Bushimbwa Tambatamba | Zendy; Stewart E. Reid | Zendy; A. Mwango | Zendy; Alwyn Mwinga | Zendy; Marc Bulterys | Zendy; Michael S. Saag | Zendy; Jeffrey S. A. Stringer | Zendy

Open Access

Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia

Author(s) -

B. H.,

Ronald A. Cantrell,

I. Zulu,

Lloyd Mulenga,

Jens Levy,

Bushimbwa Tambatamba,

Stewart E. Reid,

A. Mwango,

Alwyn Mwinga,

Marc Bulterys,

Michael S. Saag,

Jeffrey S. A. Stringer

Publication year - 2009

Publication title -

international journal of epidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.406

H-Index - 208

eISSN - 1464-3685

pISSN - 0300-5771

DOI - 10.1093/ije/dyp004

Subject(s) - medicine , antiretroviral therapy , hazard ratio , viral load , cohort , human immunodeficiency virus (hiv) , public health , immunology , confidence interval , pathology

High-level adherence to antiretroviral therapy (ART) is associated with favourable patient outcomes. In resource-constrained settings, however, there are few validated measures. We examined the correlation between clinical outcomes and the medication possession ratio (MPR), a pharmacy-based measure of adherence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research